Commons Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
8,626
+56
| +0.7% | +$2.59K | 0.3% | 59 |
|
|
2025
Q1 | $523K | Buy |
8,570
+70
| +0.8% | +$4.27K | 0.48% | 46 |
|
|
2024
Q4 | $481K | Sell |
8,500
-28
| -0.3% | -$1.58K | 0.43% | 52 |
|
|
2024
Q3 | $441K | Sell |
8,528
-18
| -0.2% | -$931 | 0.49% | 36 |
|
|
2024
Q2 | $355K | Buy |
+8,546
| New | +$355K | 0.43% | 34 |
|
|
2023
Q2 | – | Sell |
-3,907
| Closed | -$271K | – | 65 |
|
|
2023
Q1 | $271K | Sell |
3,907
-1,130
| -22% | -$78.3K | 0.43% | 50 |
|
|
2022
Q4 | $362K | Buy |
5,037
+22
| +0.4% | +$1.58K | 0.6% | 45 |
|
|
2022
Q3 | $357K | Buy |
5,015
+23
| +0.5% | +$1.64K | 0.57% | 48 |
|
|
2022
Q2 | $384K | Buy |
4,992
+2,140
| +75% | +$165K | 0.58% | 51 |
|
|
2022
Q1 | $208K | Buy |
2,852
+13
| +0.5% | +$948 | 0.22% | 102 |
|
|
2021
Q4 | $177K | Buy |
+2,839
| New | +$177K | 0.18% | 116 |
|